ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.2X leverage
Performance
- Low
- ₹8,277
- High
- ₹8,410
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,401
- Previous Close₹8,419
- Volume8,539
- 50 DMA₹8,944.53
- 100 DMA₹8,956.55
- 200 DMA₹8,679.12
Investment Returns
- Over 1 Month -7.43%
- Over 3 Month -9.95%
- Over 6 Month -8.46%
- Over 1 Year + 20.74%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 104.7
- PEG Ratio
- 0.7
- Market Cap Cr
- 20,850
- P/B Ratio
- 26.1
- Average True Range
- 208.32
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -122.38
- RSI
- 29.54
- MFI
- 12.24
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,340.00
-78.5
(-0.93%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹8,764.13
- 50 Day
- ₹8,944.53
- 100 Day
- ₹8,956.55
- 200 Day
- ₹8,679.12
Resistance and Support
8342.17
- R3 8,541.33
- R2 8,475.67
- R1 8,407.83
- S1 8,274.33
- S2 8,208.67
- S3 8,140.83
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,340 As on 12 January, 2026 | 05:32
The Market Cap of AstraZeneca Pharma India is ₹20850 Cr As on 12 January, 2026 | 05:32
The P/E ratio of AstraZeneca Pharma India is 104.7 As on 12 January, 2026 | 05:32
The PB ratio of AstraZeneca Pharma India is 26.1 As on 12 January, 2026 | 05:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.